ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Switching what heart cells consume could help them regenerate

Switching what heart cells consume could help them regenerate

Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Study shows link between use of NHB therapy and increased survival for patients with LVADs

Study shows link between use of NHB therapy and increased survival for patients with LVADs

Study compares safety and effectiveness of first-line antihypertensive drug classes

Study compares safety and effectiveness of first-line antihypertensive drug classes

First-line antihypertensives may not be most effective, study shows

First-line antihypertensives may not be most effective, study shows

Most popular first-line treatment for hypertension may be less effective than alternative drugs

Most popular first-line treatment for hypertension may be less effective than alternative drugs

Rapamycin is more effective at slowing down aging, says researcher

Rapamycin is more effective at slowing down aging, says researcher

Heart failure medication often prescribed in lower dosages than recommended

Heart failure medication often prescribed in lower dosages than recommended

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

ESC guidelines highlight detrimental impact of pollution, noise on patients with chronic coronary syndromes

ESC guidelines highlight detrimental impact of pollution, noise on patients with chronic coronary syndromes

FDA approves novel device to treat symptoms associated with advanced heart failure

FDA approves novel device to treat symptoms associated with advanced heart failure

Women more likely to be under-treated for heart disease

Women more likely to be under-treated for heart disease

Blood pressure medication associated with increased risk of diverticulosis

Blood pressure medication associated with increased risk of diverticulosis

Chemotherapy can wreak havoc on the heart

Chemotherapy can wreak havoc on the heart

Research paves way for new treatment to protect people from cardiovascular disease

Research paves way for new treatment to protect people from cardiovascular disease

Antihypertensive drug use linked with reduction in dementia risk

Antihypertensive drug use linked with reduction in dementia risk

Study shows improvements in cardiovascular risk for women developing Type 2 diabetes despite prescription bias

Study shows improvements in cardiovascular risk for women developing Type 2 diabetes despite prescription bias

New device approved by FDA for treating patients with moderate-to-severe heart failure

New device approved by FDA for treating patients with moderate-to-severe heart failure